Category: News

David Sunseri, Ph.D. to Lead the Company Through Next Phase of Growth March 1, 2021 – Essex Junction, VT:  Haematologic Technologies (“HTI”), a global leader in large molecule bioanalysis and biologic reagents, today announced the appointment of David Sunseri, Ph.D. as President and Chief Executive Officer. David will lead the… Read More
Read Full Article

A recent publication highlighting our recombinant protein characterization services performed on rIX from Emergent BioSolutions, Inc. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779506/… Read More
Read Full Article